The company announced the lawsuit Oct. 22, saying the U.S. government is seeking to put undue blame on it and eschewing its own role in the opioid epidemic. Walmart is seeking a federal judge’s declaration that the government does not have the grounds to pursue civil damages from the company for filling prescriptions that the government should have noticed were suspicious.
The lawsuit names the justice department, Attorney General William Barr, the DEA, and the DEA’s acting administrator, Timothy Shea, as defendants.
“In the shadow of their own profound failures, DOJ and DEA now seek to retroactively impose on pharmacists and pharmacies unworkable requirements that are not found in any law and go beyond what pharmacists are trained and licensed to perform,” the lawsuit, which was filed in federal court in the Eastern District of Texas, reads.
More articles on opioids:
West Virginia court orders Walmart to turn over opioid documentation
J&J adds $1B to opioid settlement
Purdue Pharma to dissolve, pay $8.3B for role in opioid epidemic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
